Geographic atrophy
Geographic Atrophy is a form of Age-related Macular Degeneration (AMD) that affects the retina and can lead to severe vision loss and blindness. It is characterized by the progressive and irreversible loss of photoreceptor cells, retinal pigment epithelium (RPE), and choriocapillaris in the macula, the part of the eye responsible for sharp, central vision.
Causes[edit | edit source]
The exact cause of Geographic Atrophy is unknown, but it is believed to be associated with the aging process and the cumulative effect of oxidative stress on the retinal tissues. Other risk factors include genetics, smoking, and nutrition.
Symptoms[edit | edit source]
The primary symptom of Geographic Atrophy is a gradual loss of central vision in one or both eyes. This can make it difficult to read, drive, or recognize faces. Other symptoms may include difficulty adapting to low light levels, needing increasingly bright light to see up close, and decreased intensity or brightness of colors.
Diagnosis[edit | edit source]
Geographic Atrophy is diagnosed through a comprehensive eye examination that includes a visual acuity test, dilated eye exam, and optical coherence tomography (OCT). Other diagnostic tests may include fundus autofluorescence (FAF), fluorescein angiography (FA), and indocyanine green angiography (ICGA).
Treatment[edit | edit source]
There is currently no cure for Geographic Atrophy. Treatment is focused on slowing the progression of the disease and managing symptoms. This may include vitamin supplements, low vision aids, and occupational therapy to help patients adapt to their changing vision.
Prognosis[edit | edit source]
The prognosis for Geographic Atrophy varies. Some people may maintain usable vision for many years, while others may experience a rapid progression of vision loss. Regular eye exams and early detection can help manage the disease and preserve vision.
See Also[edit | edit source]
Geographic atrophy Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD